Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12161678
Compositions for fecal floral transplantation and methods for making and using them and device for delivering them
granted -
US 12163192
Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof
granted -
US 12163168
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
granted -
US 12163148
Directed editing of cellular RNA via nuclear delivery of CRISPR/Cas9
granted -
US 12163169
Inducible chimeric cytokine receptors
granted -
US 12161696
Methods of treating hemophilic arthropathy using chimeric clotting factors
granted -
US 12161648
Covalent targeting of E3 ligases
granted -
US 12161672
Chimeric antigen receptor and methods of use thereof
granted -
US 12161621
Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease
granted -
US 12161632
Compositions and methods of treating cardiac fibrosis with ifetroban
granted -
US 12161620
Devices and methods for facilitating and controlling use of a medication
granted -
US 12162837
Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same
granted -
US 12162853
Synthesis of esuberaprost prodrugs
granted -
US 12161618
Methods of identifying and treating patients with HIF-2 inhibitor resistance
granted -
US 12161097
Non-human animals having a humanized signal-regulatory protein gene
granted -
US 12162821
Treatment of cataplexy
granted -
US 12161755
Sustained release device for treatment of Parkinson's disease and other disorders
granted -
US 12161607
Combination of cannabinoids in the treatment of leukemia
granted -
US 12161724
Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens
granted -
US 12161717
CD38 modulating antibody agents
granted -
WO 2024249235
CONJUGUÉS ANTICORPS-MÉDICAMENT D'AGENT DE DÉGRADATION DE BET ANTI-CD33 HUMAIN
granted -
WO 2024249615
EXOSOMES DE LAIT BOVIN POUR ADMINISTRER DE LA VITAMINE D
granted -
US 2024398790
TREATING SPONDYLOARTHRITIC CONDITIONS WITH UPADACITINIB
granted -
US 12157735
Compounds for targeted degradation of BRD9
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.